TSI Medical to distribute Ingen's OxyView; Ingen to trade on OTCBB

By E. Janene Geiss

Philadelphia, Jan. 20 - Ingen Technologies, Inc. said Friday that TSI Medical, Ltd. has agreed to distribute OxyView in North America.

The company also announced that it is finalizing plans to move the company's stock to the Over-the-Counter Bulletin Board from the Nasdaq OTC market, according to a company news release.

The completion of Securities and Exchange Commission filings is expected to take 30 to 60 days depending on the SEC's satisfaction of the Edgar filings, Thomas Neavitt, chief financial officer of Ingen, said in the release.

The company's newest product, OxyView, has a patent pending and is a pneumatic gauge that provides visual safety warning of oxygen flow for patients in the hospital, surgical room, outpatient therapy, nursing homes and emergency response facilities.

OxyView is a lightweight gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of the oxygen flow rate near the patient. It could quickly inform the physician or technician of any leak or inaccuracy between the delivery source and the patient, officials said.

No other details about the distribution deal with TSI were released.

TSI Medical is a Sherwood Park, Alta., marketer of medical devices in Canada and the United States with a focus on the physician and hospital markets.

Ingen is a Calimesa, Calif., medical device manufacturer and a growth-oriented company that owns U.S. patents, trademarks and proprietary medical products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.